Persistent Asset Partners »

Protara Therapeutic shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $57k 11k 5.33

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Protara Therapeutic

Henderson Group
Velan Capital Investment Management
BlackRock
Vanguard Group
Integral Health Asset Management
Blackstone Group
Acorn Capital Advisors
Catalio Capital Management
5AM Venture Management
UBS Group
ADAR1 Capital Management
Geode Capital Management
Maven Securities
Millennium Management
Sphera Funds Management

View all funds holding Protara Therapeutic